Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.31 USD | +3.12% | +2.90% | -36.01% |
Mar. 25 | Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 12 | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-36.01% | 3.71M | |
-0.02% | 42.11B | |
+46.17% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- FNCH Stock
- News Finch Therapeutics Group, Inc.
- Finch Therapeutics Secures two US Patents for Microbiome Therapeutic Product to Treat Autism Spectrum Disorder